PROCEPT BioRobotics Corporation (PRCT)
NASDAQ: PRCT · IEX Real-Time Price · USD
49.42
+0.58 (1.19%)
At close: Mar 28, 2024, 4:00 PM
49.94
+0.52 (1.05%)
After-hours: Mar 28, 2024, 7:57 PM EDT
PROCEPT BioRobotics Market Cap
PROCEPT BioRobotics has a market cap or net worth of $2.37 billion as of March 28, 2024. Its market cap has increased by 62.48% in one year.
Market Cap
2.37B
Enterprise Value
2.19B
1-Year Change
62.48%
Ranking
Category
Stock Price
$49.42
Market Cap Chart
Since the IPO on September 15, 2021, PROCEPT BioRobotics's market cap has increased from $1.06B to $2.37B, an increase of 123.92%. That is a compound annual growth rate of 37.50%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 27, 2024 | 2.49B | 5.19% |
Mar 26, 2024 | 2.37B | -1.23% |
Mar 25, 2024 | 2.40B | -1.39% |
Mar 22, 2024 | 2.43B | -2.32% |
Mar 21, 2024 | 2.49B | 0.56% |
Mar 20, 2024 | 2.47B | -3.06% |
Mar 19, 2024 | 2.55B | 2.79% |
Mar 18, 2024 | 2.48B | 2.33% |
Mar 15, 2024 | 2.43B | -0.21% |
Mar 14, 2024 | 2.43B | -4.96% |
Mar 13, 2024 | 2.56B | 3.15% |
Mar 12, 2024 | 2.48B | 0.74% |
Mar 11, 2024 | 2.46B | -2.01% |
Mar 8, 2024 | 2.51B | - |
Mar 7, 2024 | 2.51B | 4.47% |
Mar 6, 2024 | 2.40B | 1.70% |
Mar 5, 2024 | 2.36B | -3.09% |
Mar 4, 2024 | 2.44B | -2.45% |
Mar 1, 2024 | 2.50B | 1.49% |
Feb 29, 2024 | 2.46B | -2.13% |
Feb 28, 2024 | 2.52B | -1.78% |
Feb 27, 2024 | 2.56B | 3.91% |
Feb 26, 2024 | 2.47B | 0.02% |
Feb 23, 2024 | 2.47B | -0.67% |
Feb 22, 2024 | 2.48B | 1.30% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Alpine Immune Sciences | 2.46B |
Rocket Pharmaceuticals | 2.43B |
Patterson Companies | 2.43B |
Kymera Therapeutics | 2.42B |
TG Therapeutics | 2.42B |
Rhythm Pharmaceuticals | 2.38B |
ICU Medical | 2.37B |
Keros Therapeutics | 2.37B |